Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lenipsor+
- Development stage
- Unknown
- Lead developer
- iDelivery
- Modality
- Nanoparticles → Drug Delivery Systems
- Administration
- Topical
01
Overview
Lenipsor+ is a topical dermocosmetic and medical device developed by the Italian biotech startup iDelivery for the management of psoriasis. The product is formulated as a gel containing a patented phyto-complex extract derived from *Daphne laureola*. It is designed to improve the appearance of skin affected by desquamation, plaques, and erythema typical of psoriatic dermatitis. The treatment leverages iDelivery's specialized nanocarrier delivery systems to enhance the efficacy of its natural active ingredients. Clinical evaluation includes in vitro and in vivo testing on over 200 patients, and the product is protected by international patents in Europe, the USA, Canada, and Japan. It is positioned as a low-cost topical solution for psoriatic plaques.
- Brand names
- Lenipsor+Lenipsor+ BioActive GEL
- Other names
- Lenipsor
Beyond the preview
Go deeper on Lenipsor+.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lenipsor+.